Antibiotic-loaded bone cements

Drug-Device Combination Products: Delivery Technologies and Applications

Volumn , Issue , 2009, Pages 190-218

  Farrar, D ^a   Benson, R ^a   Milner, R ^a  

^a Smith and Nephew Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROPLASTY; BONE CEMENT; ESTERS; JOINT PROSTHESES;

COMBINATION PRODUCTS; COMMERCIAL PRODUCTS; ELUTION PROFILES; HANDLING CHARACTERISTICS; JOINT REPLACEMENT; ORTHOPAEDIC IMPLANTS; PERFORMANCE CHARACTERISTICS; TOTAL JOINT REPLACEMENT;

ANTIBIOTICS;

EID: 84903354981     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845697488.2.190     Document Type: Chapter

References (140)

1. Thonse R., Conway J.D. Antibiotic cement-coated nails for the treatment of infected nonunions and segmental bone defects. J Bone Joint Surg Am 2008, 90:163-174.
2. Taggart T., Kerry R.M., Norman P., Stockley I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br 2002, 84-B:70-72.
3. Gordon S.M., Culver D.H., Simmons B.P., Jarvis W.R. Risk factors for wound infections after total knee arthroplasty. Am J Epidemiol 1990, 131(5):905-916.
4. Coste J.S., Reig S., Trojani C., Berg M., Walch G., Boileau P. The management of infection in arthroplasty of the shoulder. J Bone Joint Surg Br 2004, 86-B:65-69.
5. Grimer R.J., Abudu A. Infection after total hip arthroplasty. J Bone Joint Surg Br 2005, 87(4):588.
6. Lie S.A., Havelin L.I., Fumes O.N., Engesaeter L.B., Vollset S.E. Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br 2004, 86(4):504-509.
7. Haddad F.S., Muirhead-Allwood S.K., Manktlow A.R.J., Bacarese-Hamilton I. Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br 2000, 82-B:689-694.
8. Hoad-Reddick D.A., Evans C.R., Norman P., Stockley I. Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty?. J Bone Joint Surg Br 2005, 87-B:171-174.
9. Blom A.W., Taylor A.H., Pattison G., Whitehouse S., Bannister G.C. Infection after total hip arthroplasty. J Bone Joint Surg Br 2003, 85-B:956-959.
10. Brouqui P., Rousseau M.C., Stein A., Drancourt M., Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 1995, 39(11):2423-2425.
11. Tunney M.M., Patrick S., Curran M.D., Ramage G., Hanna D., Nixon J.R., Gorman S.P., Davis R.I., Anderson N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999, 37(10):3281-3290.
12. Stein A., Bataille J.F., Drancourt M., Curvale G., Argenson J.N., Groulier P., Raoult D. Ambulatory treatment of multidrug-resistant Staphylococcus-Mected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998, 42(12):3086-3091.
13. Prosthetic Joint Infections: MUSC Center of Excellence, Prosthetic Joint Infection(PJI): Epidemiology. http://www.musc.edu/bmt738/DC2003/JuanManuel/1-Design/PJI-Static.html.
14. Marberry K.M., Kazmier P., Simpson W.A., Christensen G.D., Phaup J.G., Hendricks K.J., Anglen J.O., Gainor B.J. Surfactant wound irrigation for the treatment of staphylococcal clinical isolates. Clin Orthop Relat Res 2002, 403:73-79.
15. Volin S.J., Hinrichs S.H., Garvin K.L. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 2004, 427:94-100.
16. Springer B.D., Lee G.C., Osmon D., Haidukewych G.J., Hanssen A.D., Jacofsky P.J. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 2004, 427:47-51.
17. Engesaeter L.B., Lie S.A., Espehaug B., Fumes O., Vollset S.E., Havelin L.I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003, 74(6):644-651.
18. Van De Belt H., Neut D., Schenk W., Van Horn J.R., Van Der Mei H.C., Busscher H.J. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001, 72(6):557-571.
19. Kendall R.W., Duncan C.P., Beauchamp C.P. Bacterial growth on antibiotic-loaded acrylic cement. A prospective in vivo retrieval study. J Arthroplasty 1995, 10(6):817-822.
20. Pickering S.A., Bayston R., Scammell B.E. Electromagnetic augmentation of antibiotic efficacy in infection of orthopaedic implants. J Bone Joint Surg Br 2003, 85(4):588-593.
21. Ridgeway S., Wilson J., Coello R., Pearson A., Charlet A., Kafatos G. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005, 87-B(6):844-850.
22. Trampuz A., Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005, 135:243-251.
23. Lewis K. Audit of timing of antibiotic prophylaxis in hip and knee arthroplasty. J R Coll Surg Edin 1998, 43:339-340.
24. Laporte D.M., Waldman B.J., Mont M.A., Hungerford D.S. Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg Br 1999, 81-B:56-59.
25. Gaine W.J., Ramamohan N.A., Hussein N.A., Hullin M.G., Mccreath S.W. Wound infection in hip and knee arthroplasty. J Bone Joint Surg Br 2000, 82-B:561-565.
26. Atkins B.L., Athanasou N., Deeks J.J., Crook D.W., Simpson H., Peto T.E., Mclardy-Smith P., Berendt A.R. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty, The OSIRIS Collaborative Study Group. J Clin Microbiol 1998, 36(10):2932-2939.
27. Kurtz S.M., Ong K.L., Schmier J., Mowat F., Saleh K., Dybvik E., KäRrholm J., Garellick G., Havelin L.I., Fumes O., Malchau H., Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89(3):144-151.
28. Widmer A.F. New developments in diagnosis and treatment of infection in orthopaedic implants. Clin Infect Dis 2001, 33(S2):S94-S106.
29. James L.A., Ibrahim T., Esler C.N. Microbiological culture results for the femoral head. J Bone Joint Surg Br 2004, 86-B:797-800.
30. Schierholz J.M., Beuth J. Implant infections: a haven for opportunistic bacteria. J Hospital Infection 2001, 49:87-93.
31. Gristina A.G. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res 1994, 298:106-118.
32. Thornes B., Murray P., Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 2002, 84-B:758-760.
33. Rao N., Ziran B.H., Hall R.A., Santa E.R. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004, 427:67-71.
34. Garvin K.L., Evans B.G., Salvati E.A., Brause B.D. Palacos gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop Relat Res 1994, 298:97-105.
35. Price J.S., Tencer A.F., Arm D.M., Bohach G.A. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 1996, 30(3):281-286.
36. Trebse R., Pisot V., Trampuz A. Treatment of infected retained implants. J Bone Joint Surg Br 2005, 87(2):249-256.
37. Giannoudis P.V., Wilcox M.H., Parker J. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br 2005, 87-B(6):749-754.
38. Hsieh P.H., Shih C.H., Chang Y.H., Lee M.S., Shih H.N., Yang W.E. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 2004, 86-A(9):1989-1997.
39. Evans R.P. Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res 2004, 427:37-46.
40. Buttaro M.A., Pusso R., Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. J Bone Joint Surg Br 2005, 87-B:314-319.
41. Rutledge B., Huyette D., Day D., Anglen J. Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer. Clin Orthop Relat Res 2003, 411:280-287.
42. Mader J.T., Stevens C.M., Stevens J.H., Ruble R., Lathrop J.T., Calhoun J.H. Treatment of experimental osteomyelitis with a fibrin sealant antibiotic implant. Clin Orthop Relat Res 2002, 403:58-72.
43. Hassett D.J., Cuppoletti J., Trapnell B., Lymar S.V., Rowe J.J., Yoon S.S., Hilliard G.M., Parvatiyar K., Kamani M.C., Wozniak D.J., Hwang S.H., Mcdermott T.R., Ochsner U.A. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 2002, 54(11):1425-1443.
44. Charnley J. Acrylic Cement in Orthopaedic Surgery 1970, Williams and Wilkins, Baltimore.
45. Kuhn K.-D. Bone Cements - Up-to-date Comparison of Physical and Chemical Properties of Commercial Materials 2000, 1-5. Spinger-Verlag, Berlin.
46. Apple D.J., Sims J. Harold Ridley and the invention of the intraocular lens. Surv Opththalmol 1996, 40:279-292.
47. Kulzer Patent DRP737058 1936.
48. Czapp A.E., Schnebel E., Goelz A. Degussa Patent DRP973590 1941.
49. Reckling F.W., Dillon W.L. The bone-cement interface temperature during total joint replacement. J Bone Joint Surg Am 1977, 59-A:80-82.
50. Feith R. Side effects of acrylic cement implanted into bone. Acta Orthop Scand 1975, (Supplementen 161).
51. Swenson L.W., Schurman D.J., Piziali R.L. Finite element temperature analysis of a total hip replacement and measurement of PMMA curing temperatures. J Biomed Mater Res 1981, 15:83-96.
52. Wheelwright E.F., Byrick R.J., Wigglesworth D.F., Kay J.C., Wong P.Y., Mullen J.B., Waddall J.P. Hypotension during cemented arthroplasty: relationship to cardiac output and fat embolism. J Bone Joint Surg Br 1993, 75-B:715-723.
53. Lazarus M.D., Cuckler J.M., Mitchell J., Schumacher H.R., Baker D.G., Ducheyne P., Imonite V. Biocompatibility of polymethyl methcarylate with and without barium sulfate in the rat subcutaneous air pouch model. Paniculate Debris from Medical Implants: Mechanisms of formation and biological consequences 1992, 127-135. Amer Soc For Testing and Materials, Philadephia, ASTM STP 1144. K.R. St John (Ed.).
54. Weisman G., Wilder D., Pope M. Dimensional changes during the polymerization of polymethyl methacrylate (PMMA) 1976, 123-126. Pergamon Press, Oxford. S. Saha (Ed.).
55. Buchholz H.W., Elson R.A., Engelbrecht E., LodenkäMper H., RöTtger J., Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981, 63-B:342-353.
56. Hunter G., Dandy D.J. The natural history of the patient with an infected total hip replacement. J Bone Joint Surg Br 1977, 59-B:293-297.
57. Joseph T.N., Chen A.L., Di Cesare P.E. Use of antibiotic-impregnated cements in total joint arthroplasty. J Acad Ortho Surg 2003, 11:38-47.
58. Wroblewski B.M., Esser M., Srigley D.W. Release of gentamicin from bone cement: anex vivo study. Acta Orthop Scand 1986, 57:413-414.
59. The Norwegian Arthroplasty Register Annual Report Department of Orthopaedics, Haukeland University Hospital, Norway, 2004. http://www.haukeland.no/nrl/Report2004.pdf.
60. The Swedish National Hip Arthroplasty Register Department of Orthopaedics Sahlgrenska University Hospital, Sweden 2004. http://www.jru.orthop.gu.se.
61. Fish D.N., Hoffman M., Danziger L.H. Antibiotic-impregnated cement use in U.S. hospitals. Am J Hosp Pharm 1992, 49:2469-2473.
62. Heck D., Rosenberg A., Schink-Ascani M., Garbus S., Kiewitt T. Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States. J Arthoplasty 1995, 10:470-475.
63. Kucers A., Bennett N, Mck The Use of Antibiotics 1987, Heinemann. 4th edn.
64. Forster H., Marotta J.S., Heseltine K., Milner R., Jani S. Bacterial activity of antimicrobial coated polyurethane sleeves for external fixator pins. J Orthop Res 2004, 22:671-677.
65. Hendriks J.G., Neut D., Van Horn J.R., Van Der Mei H.C., Busscher H.J. Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. J Bone Joint Surg Br 2005, 87(2):272-276.
66. Lorian M.D. Antibiotics in Laboratory Medicine 1986, Williams & Wilkins. 2nd edn.
67. Martindale - the Extra Pharmacopoeia 1989, The Parmaceutical Press. 29th edn. J.E.F. Reynolds (Ed.).
68. Wahlig H., Dingeldein E. Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 1980, 51:49-56.
69. Downes S., Brown A.E., Mukherjee S. The clearance of gentamicin from antibiotic-loaded bone cement. International Orthopaedics (SICOT) 1985, 9:205-207.
70. Lindbeg L., Onnerfalt R., Dingeldein E., Wahlig H. The release of gentamicin after total hip replacement using low or high viscosity bone cement - a prospective, randomised study. International Orthopaedics (SICOT) 1991, 15:305-309.
71. Bunetel L., Segui A., Cormier E., Percheron E., Langlais F. Release of gentamicin from acrylic bone cement. Clin Pharmacokinet 1989, 17:291-297.
72. Buranapanitkit B., Srinilta V., Ingviga N., Oungbho K., Geater A., Ovatlarnporn C. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin Orthop Relat Res 2004, 424:244-252.
73. Marks K.E., Nelson C.L., Lautenschlager E.P. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg Am 1976, 58-A(3):358-364.
74. Levin P.D. The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint Surg Br 1975, 57-B(2):234-237.
75. Penner M.J., Masri B.A., Duncan C.P. Elution characterisation of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996, 11(8):939-944.
76. Klekemp J., Dawson J.M., Haas D.W., Deboer D., Christie M. The use of vancomycin and tobramycin in acrylic bone cement. Biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999, 14(3):339-346.
77. Brien W.W., Salvati E.A., Klein R., Brause B., Stern S. Antibiotic impregnated bone cement in total hip arthroplasty: an in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop Reí Res 1993, 296:242-248.
78. Anagnostakos K., Keim J., Regitz T., Schmitt E., Jung W. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res Part B: Appl Biomater 2005, 72-B:373-378.
79. Simpson P.M., Dall G.F., Breusch S.J., Heisel C. In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements. Orthopade 2005, 34(12):1255-1262.
80. Goss B., Lutton C., Weinrauch P., Jabur M., Gillett G., Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty 2007, 22(6):902-908.
81. Hsieh P.-H., Tai C.-L., Lee P.-C., Chang Y.-H. Liquid gentamicin and vancomycin in bone cement: a potentially more cost-effective regimen. J Arthroplasty 2009, 24(1):125-130.
82. Baleani M., Persson C., Zolezzi C., Andollina A., Borelli A.M., Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 2008, 23(8):1232-1238.
83. Van De Belt H., Neut D., Uges D.R.A., Schenk W., Van Horn J.R., Van Der Mei H.C., Busscher H.J. Surface roughness, porosity, and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials 2000, 21:1981-1987.
84. Dall G.F., Simpson P.M.S., Breusch S.J. In vitro comparison of Refobacin-Palacos R with Refobacin Bone Cement and Palacos R+G. Acta Orthop 2007, 78(3):404-411.
85. Squire M.W., Ludwig B.J., Thompson J.R., Jagodzinski J., Hall D., Andes D. Premixed antibiotic bone cement: an in vitro comparison of antimicrobial efficacy. J Arthroplasty 2008, 23(6 Suppl):110-114.
86. He Y., Trotignon J.P., Loty B., Tcharkhtchi A., Verdu J. Effect of antibiotics on the properties of poly(methyl methacrylate)-based bone cement. J Biomed Mater Res (Appl Biomater) 2002, 63:800-806.
87. Lewis G., Janna S. Estimation of the optimum loading of an antibiotic powder in an acrylic bone cement. Acta Orthop 2006, 77(4):622-627.
88. Dunne N., Hill J., Mcafee P., Todd K., Kirkpatrick R., Tunney M., Patrick S. In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin. Acta Orthop 2007, 78(6):774-785.
89. Dunne N.J., Hill J., Mcafee P., Kirkpatrick R., Patrick S., Tunney M. Incorporation of large amounts of gentamicin sulphate into acrylic bone cement: effect on handling and mechanical properties, antibiotic release, and biofilm formation. Proc IMechE Part H: J Engineering in Medicine 2008, 222:355-365.
90. Neut D., Van De Belt H., Van Horn J.R., Van Der Mei H.C., Busscher H.J. The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 2003, 74(6):670-676.
91. Lewis G., Janna S., Bhattaram A. Influence of the method of blending an antibiotic powder with an acrylic bone cement powder on physical, mechanical, and thermal properties of the cured cement. Biomaterials 2005, 26:4317-4325.
92. Powles J.W., Spencer R.F., Lovering A.M. Gentamicin release from old cement during revision arthroplasty. J Bone Joint Surg Br 1998, 80-B:607-610.
93. Lewis G., Janna S. The in vitro elution of gentamicin sulphate from a commercially available gentamicin-loaded acrylic bone cement, Versabond™ AB. J. Biomed Mater Res Part B: Appl Biomater 2004, 71-B:77-83.
94. Masri B.A., Duncan C.P., Beauchamp C.P., Paris N.J., Arntorp J. Effect of varying surface patterns on antibiotic elution from antibiotic-loaded bone cement. J Arthroplasty 1995, 10(4):453-459.
95. Bayston R., Milner R.D.G. The sustained release of antimicrobial drugs from bone cement: an appraisal of laboratory investigations and their significance. J Bone Joint Surg Br 1982, 64-B(4):460-464.
96. Frutos Cabanillas P, Diez Pena E, Barrelas-Rienda M., Frutos G. Validation and in vitro characterization of antibiotic-loaded bone cement release. Int J Pharmaceutics 2000, 209:15-26.
97. Torrado S., Frutos P., Frutos G. Gentamicin bone cements: characterisation and release (in vitro and in vivo assays). Int J Pharmaceutics 2001, 217:57-69.
98. Lewis G., Bhattaram A. Influence of a pre-blended antibiotic (gentamicin sulphate powder) on various mechanical, thermal, and physical properties of three acrylic bone cements. J Biomater Appl 2006, 20:377-408.
99. Lautenschlager E.P., Marshall G.W., Marks K.E., Schwartz J., Nelson C.L. Mechanical strength of acrylic bone cements impregnated with antibiotics. J Biomed Mater Res 1976, 10:837-845.
100. Dall G.F., Simpson P.M.S., Mackenzie S.P., Breusch S.J. Inter- and intra-batch variability in the handling characteristics and viscosity of commonly used antibiotic-loaded bone cements. Acta Orthop 2007, 78(3):412-420.
101. Wright T.M., Sullivan D.J., Arnoczky S.P. The effect of antibiotic additions on the fracture properties of bone cements. Acta Orthop Scand 1984, 55:414-418.
102. Rimnac C.M., Wright T.M., Mcgill D.L. The effect of centrifugation on the fracture properties of acrylic bone cements. J Bone Joint Surg Am 1986, 68-A(2):281-287.
103. Weinrauch P.C., Bell C., Wilson L., Goss B., Lutton C., Crawford R.W. Shear properties of bilaminar polymethylmethacrylate cement mantles in revision hip joint arthroplasty. J Arthroplasty 2007, 22(3):394-403.
104. Lautenschlager E.P., Jacobs J.J., Marshall G.W., Meyer P.R. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res 1976, 10:929-938.
105. Armstrong M.S., Spencer R.F., Cunningham J.L., Gheduzzi S., Miles A.W., Learmonth I.D. Mechanical characteristics of antibiotic-laden bone cement. Acta Orthop Scand 2002, 73(6):688-690.
106. Gogus A., Akman S., Goksan S.B., Bozdag E. Mechanical strength of antibiotic-impregnated bone cement on Day 0 and Day 15: a biomechanical study with Surgical Simplex P and teicoplanin. Acta Orthop Traumatol Turc 2002, 36:63-71.
107. Pelletier M.H., Malisano L., Smitham P.J., Okamoto K., Walsh W.R. The compressive properties of bone cements containing large doses of antibiotics. J Arthroplasty 2009, 24(3):454-460.
108. ISO 5833 Implants for Surgery - Acrylic Resin Cements.
109. ASTM F451 Standard Specification for Acrylic Bone Cement.
110. Leone J., Johnson A., Ziada S., Hashemi A., Adili A., De Beer J. Biaxial flexural modulus of antibiotic-impregnated orthopaedic bone cement. J Biomed Mater Res Part B: Appl Biomater 2007, 83-B:97-104.
111. Davies J.P., O'Connor D.O., Burke D.W. Influence of antibiotic impregnation on the fatigue life of Simplex P and Palacos R acrylic bone cements, with and without centrifugation. J Biomed Mater Res 1989, 23:379-397.
112. Davies J.P., Harris W.H. Effect of hand mixing tobramycin on the fatigue strength of Simplex P. J Biomed Mater Res 1991, 25:1409-1414.
113. Baleani M., Cristofolini L., Minari C., Toni A. Fatigue strength of PMMA bone cement mixed with gentamicin and barium sulphate vs pure PMMA. Proc Instn Mech Engrs Part H: J Engineering in Medicine 2003, 217:9-12.
114. Lidgren L., Bodelind B., Moller J. Bone cement improved by vacuum mixing and chilling. Acta Orthop Scand 1987, 57:27-32.
115. Jiranek W.A., Hanssen A.D., Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006, 88-A:2487-2500.
116. Hanssen A.D. Prophylactic use of antibiotic bone cement: an emerging standard - in opposition. J Arthroplasty 2004, 19(4):73-77.
117. Wininger D.A., Fass R.J. Antibiotic-impregnated cement and beads for orthopaedic infections. Antimicrob Agents Chemother 1996, 40(12):2675-2679.
118. Klemm K.W. Antibiotic bead chains. Clin Orthop 1993, 295:63-76.
119. Wahlig H., Dingeldein E., Bergmann R., Reuss K. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study. J Bone Joint Surg Br 1978, 60-B(2):270-275.
120. Boda A. Septopal-chain exchange operation for the treatment of osteomyelitic cavities. Arch Orthop Trauma Surg 1982, 101:39-45.
121. Henry S.H., Hood G.A., Seligson D. Long-term implantation of gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop 1993, 295:47-53.
122. Walenkamp G.H.I.M., Kleijn L.L.A., De Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 1998, 69(5):518-522.
123. Mohanty S.P., Kumar M.N., Murthy N.S. Use of antibiotic-loaded polymethyl methacrylate beads in the management of musculoskeletal sepsis - a retrospective study. J Orthop Surg 2003, 11(1):73-79.
124. Minelli E.B., Benini A., Magnan B., Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 2004, 53:329-334.
125. Stevens C.M., Tetsworth K.D., Calhoun J.H., Mader J.T. An articulated antibiotic spacer used for infected total knee arthroplasty: a comparative in vitro elution study of Simplex® and Palacos® bone cements. J Orthop Res 2005, 23:27-33.
126. Anagnostakos K., Keim J., Gran S., Schmitt E., Jung W., Swoboda S. Antimicrobial properties and elution kinetics of linezolid-loaded hip spacers in vitro. J Biomed Mater Res Part B: Appl Biomater 2008, 87-B:173-178.
127. Haddad F.S., Masri B.A., Campbell D., Mcgraw R.W., Beauchamp C.P., Duncan C.P. The PROSTALAC functional spacer in two-stage revision for infected knee replacements. J Bone Joint Surg Br 2000, 82-B:807-812.
128. Scharfenberger A., Clark M., Lavoie G., O'Connor G., Masson E., Beaupré L.A. Treatment of an infected total hip replacement with the PROSTALAC system. J Can Chir 2007, 50(1):24-28.
129. Bosetti M., Massè A., Tobin E., Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials 2002, 23:887-892.
130. Collinge C.A., Goll G., Seligson D., Easley K.J. Pin tract infections: silver vs. uncoated pins. Orthopedics 1994, 17:445-448.
131. Ewald A., GlüCkermann S.K., Thull R., Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng online 2006, 5:22.
132. Chen W., Liu Y., Courtney H.S., Bettenga M., Agrawal C.M., Bumgardner J.D., Ong J.L. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006, 27:5512-5517.
133. Chen W., Oh S., Ong A.P., Oh N., Liu Y., Courtney H.S., Appleford M., Ong J.L. Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process. J Biomed Mater Res A 2007, 82:899-906.
134. Sawan S.P., Manivannan G. Antimicrobial/Anti-infective Materials: Principles, Applications and Devices 1999, CRC Press.
135. Schmidmaier G., Lucke M., Wildemann B., Haas N.P., Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 2006, 37(Suppl 2):S105-S112.
136. Darouiche R.O., Farmer J., Chaput C., Mansouri M., Saleh G., Landon G.C. Anti-infective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg Am 1998, 80:1336-1340.
137. Dunn D.S., Raghavan S., Volz R.G. Gentamicin sulfate attachment and release from anodized Tí-6A1-4V orthopedic materials. J Biomed Mater Res 1993, 27:895-900.
138. Aviv M., Berdicevsky I., Zilberman M. Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J Biomed Mater Res A 2007, 83:10-19.
139. Popat K.C., Eltgroth M., Latempa T.J., Grimes C.A., Desai T.A. Decreased staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007, 28:4880-4888.
140. Antoci V., Adams C.S., Hickok N.J., Shapiro I.M., Parvizi J. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Rel Res 2007, 461:88-95.